Cosyntropin vs Somatostatin
Head-to-head comparison of Cosyntropin (Cosyntropin (ACTH 1-24)) and Somatostatin (Somatostatin-14) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Cosyntropin | Somatostatin |
|---|---|---|
| Category | Pain Management | Pain Management |
| Full Name | Cosyntropin (ACTH 1-24) | Somatostatin-14 |
| Molecular Weight | 2933.3 Da | 1637.85 |
| Half-Life | ~10 min | 1-3 min |
| Amino Acids | 24 | 14 |
| Typical Dose | 0.25 mg IV/IM diagnostic dose|off-label headache protocols vary | N/A|N/A |
| Route | IV|IM | IV/SC |
| Purity | ≥98% | ≥98% |
| Studies Count | 61 | 84 |
| Research Status | Clinical research | Approved |
Cosyntropin Benefits
- ✓refractory migraine
- ✓anti-inflammatory signaling
- ✓headache rescue research
Somatostatin Benefits
- ✓nociceptive inhibition
- ✓anti-inflammatory signaling
- ✓visceral pain modulation
Cosyntropin Dosing
0.25 mg IV/IM|1 mg IV/IM
Somatostatin Dosing
N/A|N/A
Cosyntropin Side Effects
- ⚠flushing
- ⚠nausea
Somatostatin Side Effects
- ⚠hyperglycemia
- ⚠bradycardia
- ⚠GI upset
Research Overview
Cosyntropin
Cosyntropin is not a standard pain drug, but it appears in headache literature because ACTH analogs can help some patients with difficult migraine attacks. The analgesic rationale is partly tied to steroidogenic and anti-inflammatory effects.
Somatostatin
Somatostatin reduces release of multiple excitatory mediators and can suppress pain signaling in preclinical and limited translational work. Its analgesic use is not standard, but the peptide is real and mechanistically relevant to pain control.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.